Amy Bachrodt

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Courtney Phillips, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy Bachrodt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Maze Therapeutics, Inc. SVP, Finance Common Stock 12,965 $589,510 $45.47 02 Mar 2026 Direct
Maze Therapeutics, Inc. SVP, Finance Stock Option (Right to Buy) 32,000 02 Mar 2026 Direct
Maze Therapeutics, Inc. SVP, Finance Restricted Stock Units 16,000 02 Mar 2026 Direct

Insider Reports Filed by Amy Bachrodt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MAZE Maze Therapeutics, Inc. 02 Mar 2026 6 -$173,911 4 SVP, Finance 03 Mar 2026, 16:20
MAZE Maze Therapeutics, Inc. 02 Feb 2026 7 -$178,119 4 SVP, Finance 04 Feb 2026, 16:23
MAZE Maze Therapeutics, Inc. 22 Jan 2026 5 -$175,512 4 SVP, Finance 26 Jan 2026, 16:10
MAZE Maze Therapeutics, Inc. 02 Jan 2026 6 -$143,654 4 SVP, Finance 06 Jan 2026, 16:30
MAZE Maze Therapeutics, Inc. 29 Dec 2025 11 -$449,873 4 SVP, Finance 31 Dec 2025, 16:20
MAZE Maze Therapeutics, Inc. 22 Sep 2025 1 $0 4 SVP, Finance 24 Sep 2025, 16:23
MAZE Maze Therapeutics, Inc. 30 Jan 2025 0 $0 3 SVP, Finance 30 Jan 2025, 16:21